The fight to effectively treat and cure the complex disease of acute myeloid leukemia (AML) continues.
In this episode, we speak to Dr. Elie Traer, Dr. Karin Rodland and Dr. Lee Greenberger about an exciting new study for AML. The doctors share about a longtime collaboration between Oregon Health & Science University (OHSU) and Pacific Northwest National Laboratory (PNNL) using patient samples from LLS’s Beat AML Master Clinical Trial to further understand the proteins on the cancer cells, resulting in the development of more targeted treatments for AML patients.
Podcast: Play in new window | Download
Subscribe: Google Podcasts | Spotify | Pandora | Blubrry | JioSaavn | Podchaser | More
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Acute Myeloid Leukemia
- Beat AML Master Clinical Trial
- Beat AML Documentary
- Stem Cell Transplant
- Mapping The Proteogenomic Landscape Enables Prediction of Drug Response in Acute Myeloid Leukemia
Additional LLS Support Resources:
- Information Specialists
- Free Nutrition Consultations
- Financial support
- Free telephone/web patient programs
- Free booklets
- Clinical Trial Support Center
- Young Adult Resources
- Caregiver support
- Caregiver Workbook
- Survivorship Workbook
- Online chats
- LLS Community
- Support groups Patti Robinson Kaufmann First Connection Program
Support for this episode provided by: Abbvie Inc. and Genentech, Inc. & Biogen.
I am an AML survivor. One day(Nov 5,2022) I was a perfectly healthy 69 yr old woman…next day I wasn’t. I was taken to Mass General Hospital where I was diagnosed, treated and received a stem cell transplant all within 3 months. The trial I was in was for the drug gilteritinib which targeted my FLT3 mutation. I believe I had THE very best care possible and have felt great for the last 14 months. Listening to this podcast reenforces my belief in just how lucky I was and how the extensive research for this disease did in fact save my life.